Lower incidence of recorded cardiovascular outcomes in patients with type 2 diabetes using insulin aspart vs. those on human regular insulin: observational evidence from general practices-Reference-Cited by-同舟云学术

Lower incidence of recorded cardiovascular outcomes in patients with type 2 diabetes using insulin aspart vs. those on human regular insulin: observational evidence from general practices

Published:2012-11-28 Issue:4 Volume:15 Page:358-363
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Rathmann W.¹,Kostev K.²

Affiliation:

1. German Diabetes Center; Institute of Biometrics and Epidemiology; Düsseldorf; Germany

2. Department LifeLink Epidemiology, IMS HEALTH; Frankfurt; Germany

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12035/fullpdf

Reference19 articles.

1. Glucose tolerance and cardiovascular mortality. Comparison of fasting and 2-hour diagnostic criteria;DECODE Study Group;Arch Intern Med,2001

2. Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study;Nakagami;Eur J Cardiovasc Prev Rehabil,2006

3. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years;Coutinho;Diabetes Care,1999

4. Postprandial hyperglycemia and diabetes complications: is it time to treat?;Ceriello;Diabetes,2005

5. Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial;Perriello;Diabet Med,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of antidiabetic medications on the cardiovascular system: a critical appraisal of current data;HORM-INT J ENDOCRINO;2018

2. Treatment with insulin analogs and prevalence of cardiovascular complications in patients with type 1 diabetes;Therapeutic Advances in Endocrinology and Metabolism;2017-10-10

3. Postprandiale Blutzuckerkontrolle;CME;2017-02

4. Besser und kostengünstiger mit Aspart;Info Diabetologie;2017-02

5. Comparative analysis of glycemic control effectiveness and microvascular complications in patients with type 1 diabetes mellitus, treated with genetically engineered human insulin or human insulin analogues: A 10-year retrospective observational study;Diabetes mellitus;2016-12-31